'Pharma bro' Martin Shkreli found guilty of securities fraud
Martin Shkreli made headlines in September 2015 after he raised the price of Daraprim, a drug used to treat a parasitic infection, by 5,000%.
August 4, 2017 at 11:50PM
via Digg http://ift.tt/2vxJMFB
No comments:
Post a Comment